广东
分享至
格隆汇10月30日｜心血管代谢药物开发商Metsera盘前涨超13%，诺和诺德据称将提高对该公司的收购报价。
特别声明：以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布，本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.
